Drug Trial Radar · NCT07287982
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Dec 19, 2025
Primary completion
May 28, 2029
Study completion May 28, 2029
Sponsor
- Lead sponsor
- argenxargenx (ARGX)
- Sponsor type
- Industry
- First posted
- Dec 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to find the correct dose of ARGX-119 for children with SMA. The study will also look at how safe the study drug is, how well it works, how it moves through the body, and how the immune system responds to it. The study consists of a double-blinded treatment period (DBTP) where participants will either receive ARGX-119 IV or placebo IV, in addition to disease-modifying therapy (DMT) for 24 weeks. Participants who complete the DBTP will enter the open-label active-treatment extension period (ATEP) during which all participants will receive ARGX-119 IV up to 100 weeks (approximately 2 years).
Conditions
- Spinal Muscular Atrophy (SMA)
Interventions
ARGX-119 IVBiological
Intravenous infusion of ARGX-119
Placebo IVOther
Intravenous infusion of placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of AEsTime frame: Up to 124 weeks
- Incidence of SAEsTime frame: Up to 124 weeks
- Change in RHS total score from baseline to week 24 of the double blinded treatment period (DBTP)Time frame: Up to 24 weeks
Locations
46 sites in 10 countries. Site status is shown where the registry gives one.
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Rady Childrens Hospital
San Diego, California · Withdrawn
Stanford University Medical Center
Stanford, California · Recruiting
Connecticut Children's Medical Center
Hartford, Connecticut · Recruiting
Rare Disease Research FL LLC
Kissimmee, Florida · Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Recruiting
University of Iowa Stead Family Children's Hospital
Iowa City, Iowa · Recruiting
The Johns Hopkins Hospital
Baltimore, Maryland · Recruiting
Boston Children's Hospital
Boston, Massachusetts · Recruiting
The Curators of the University of Missouri on behalf of University of Missouri Health Care
Columbia, Missouri · Recruiting
Columbia University Herbert Irving Comprehensive Cancer Center
New York, New York · Recruiting
Rare Disease Research NC, LLC
Hillsborough, North Carolina · Recruiting
Children's Hospital Philadelphia - Neurology
Philadelphia, Pennsylvania · Not yet recruiting
Neurology Rare Disease Center
Flower Mound, Texas · Recruiting
Texas Children's Hospital
Houston, Texas · Recruiting
Childrens Hospital of The Kings Daughters
Norfolk, Virginia · Not yet recruiting
Sydney Children's Hospital, Randwick
Randwick, New South Wales, Australia · Recruiting
Royal Children's Hospital
Parkville, Victoria, Australia · Not yet recruiting
Universitair Ziekenhuis Gent
Ghent, Belgium · Not yet recruiting
UZ Leuven
Leuven, Belgium · Not yet recruiting
C. H. R. de la Citadelle
Liège, Belgium · Not yet recruiting
University of Calgary - Alberta Children's Hospital
Calgary, Alberta, Canada · Not yet recruiting
BC Children's Hospital
Vancouver, British Columbia, Canada · Not yet recruiting
The Hospital for Sick Children
Toronto, Ontario, Canada · Withdrawn
Universitaetsklinikum Essen
Essen, Germany · Not yet recruiting
Universitaetsklinikum Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany · Not yet recruiting
Universitaetsklinikum Ulm
Ulm, Baden-Wurttemberg, Germany · Not yet recruiting
Klinikum der Universitaet Muenchen
München, Bavaria, Germany · Not yet recruiting
Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS
Genova, Italy · Not yet recruiting
Azienda Ospedaliera Universitaria Policlinico G. Martino
Messina, Italy · Not yet recruiting
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, Italy · Not yet recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Italy · Not yet recruiting
Fondazione Serena Onlus - Centro Clinico Nemo
Milan, Milano, Italy · Not yet recruiting
UMC Utrecht
Utrecht, Netherlands · Not yet recruiting
Instytut Centrum Zdrowia Matki Polki
Lodz, Poland · Not yet recruiting
Uniwersytecki Szpital Kliniczny w Poznaniu
Poznan, Poland · Not yet recruiting
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego
Warsaw, Poland · Not yet recruiting
Hospital Universitari Vall d'Hebron - VHIR
Barcelona, Spain · Not yet recruiting
Hospital Universitari i Politecnic La Fe
Valencia, Spain · Not yet recruiting
Addenbrooke's Hospital
Cambridge, Cambridgeshire, United Kingdom · Recruiting
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.